Literature DB >> 32516521

Sézary syndrome and mycosis fungoides: An overview, including the role of immunophenotyping.

Melissa P Pulitzer1, Pedro Horna2, Julia Almeida3.   

Abstract

This review discusses the definition and major categories of cutaneous T-cell lymphoma, Sézary syndrome and mycosis fungoides, and the role of immunophenotyping in their diagnosis. The following key points are raised: (a) Sézary syndrome and mycosis fungoides cells most often have a characteristic CD3+ CD4+ CD7- and/or CD26- immunophenotype. (b) This immunophenotype is not specific, but can assist in the distinction from non-neoplastic T cells and other subtypes of mature T-cell neoplasm. (c) However, small subsets of normal and reactive T-cells can have an overlapping immunophenotype, and can be distinguished by evaluating for additional changes in antigen expression.
© 2020 International Clinical Cytometry Society.

Entities:  

Keywords:  Sézary syndrome; T-cell; flow cytometry; lymphocyte; mycosis fungoides

Mesh:

Substances:

Year:  2020        PMID: 32516521      PMCID: PMC9306215          DOI: 10.1002/cyto.b.21888

Source DB:  PubMed          Journal:  Cytometry B Clin Cytom        ISSN: 1552-4949            Impact factor:   3.248


  34 in total

1.  Low CD7 expression in benign and malignant cutaneous lymphocytic infiltrates: experience with an antibody reactive with paraffin-embedded tissue.

Authors:  Michael Murphy; Doug Fullen; J Andrew Carlson
Journal:  Am J Dermatopathol       Date:  2002-02       Impact factor: 1.533

Review 2.  WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects.

Authors:  Günter Burg; Werner Kempf; Antonio Cozzio; Josef Feit; Rein Willemze; Elaine S Jaffe; Reinhard Dummer; Emilio Berti; Lorenzo Cerroni; Sergio Chimenti; José L Diaz-Perez; Florent Grange; Nancy L Harris; Dmitry V Kazakov; Helmut Kerl; Michael Kurrer; Robert Knobler; Chris J L M Meijer; Nicola Pimpinelli; Elisabeth Ralfkiaer; Robin Russell-Jones; Christian Sander; Marco Santucci; Wolfram Sterry; Steven H Swerdlow; Maarten H Vermeer; Janine Wechsler; Sean Whittaker
Journal:  J Cutan Pathol       Date:  2005-11       Impact factor: 1.587

3.  Single Antibody Detection of T-Cell Receptor αβ Clonality by Flow Cytometry Rapidly Identifies Mature T-Cell Neoplasms and Monotypic Small CD8-Positive Subsets of Uncertain Significance.

Authors:  Min Shi; Dragan Jevremovic; Gregory E Otteson; Michael M Timm; Horatiu Olteanu; Pedro Horna
Journal:  Cytometry B Clin Cytom       Date:  2019-04-11       Impact factor: 3.058

4.  Clinical end points and response criteria in mycosis fungoides and Sézary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer.

Authors:  Elise A Olsen; Sean Whittaker; Youn H Kim; Madeleine Duvic; H Miles Prince; Stuart R Lessin; Gary S Wood; Rein Willemze; Marie-France Demierre; Nicola Pimpinelli; Maria Grazia Bernengo; Pablo L Ortiz-Romero; Martine Bagot; Teresa Estrach; Joan Guitart; Robert Knobler; José Antonio Sanches; Keiji Iwatsuki; Makoto Sugaya; Reinhard Dummer; Mark Pittelkow; Richard Hoppe; Sareeta Parker; Larisa Geskin; Lauren Pinter-Brown; Michael Girardi; Günter Burg; Annamari Ranki; Maartan Vermeer; Steven Horwitz; Peter Heald; Steve Rosen; Lorenzo Cerroni; Brigette Dreno; Eric C Vonderheid
Journal:  J Clin Oncol       Date:  2011-05-16       Impact factor: 44.544

5.  Unusual variants of mycosis fungoides.

Authors:  Pooja Virmani; Patricia L Myskowski; Melissa Pulitzer
Journal:  Diagn Histopathol (Oxf)       Date:  2016-05-21

6.  Cutaneous T-cell lymphoma (CTCL): Current practices in blood assessment and the utility of T-cell receptor (TCR)-Vβ chain restriction.

Authors:  Juliet F Gibson; Jing Huang; Kristina J Liu; Kacie R Carlson; Francine Foss; Jaehyuk Choi; Richard Edelson; Jerry W Hussong; Ramsey Mohl; Sally Hill; Michael Girardi
Journal:  J Am Acad Dermatol       Date:  2016-02-10       Impact factor: 11.527

7.  Flow cytometric evaluation of skin biopsies for mycosis fungoides.

Authors:  Chris H Jokinen; Jonathan R Fromm; Zsolt B Argenyi; John Olerud; Brent L Wood; Harvey A Greisman
Journal:  Am J Dermatopathol       Date:  2011-07       Impact factor: 1.533

8.  Usefulness of KIR3DL2 to Diagnose, Follow-Up, and Manage the Treatment of Patients with Sézary Syndrome.

Authors:  Charlotte Hurabielle; Nicolas Thonnart; Caroline Ram-Wolff; Hélène Sicard; Armand Bensussan; Martine Bagot; Anne Marie-Cardine
Journal:  Clin Cancer Res       Date:  2017-01-24       Impact factor: 12.531

9.  Regulation of T-plastin expression by promoter hypomethylation in primary cutaneous T-cell lymphoma.

Authors:  Christine L Jones; Silvia Ferreira; Robert C T McKenzie; Isabella Tosi; Jacqueline A Caesar; Martine Bagot; Sean J Whittaker; Tracey J Mitchell
Journal:  J Invest Dermatol       Date:  2012-04-12       Impact factor: 8.551

Review 10.  Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.

Authors:  Sarah I Jawed; Patricia L Myskowski; Steven Horwitz; Alison Moskowitz; Christiane Querfeld
Journal:  J Am Acad Dermatol       Date:  2014-02       Impact factor: 11.527

View more
  7 in total

Review 1.  Combined High-Throughput Approaches Reveal the Signals Driven by Skin and Blood Environments and Define the Tumor Heterogeneity in Sézary Syndrome.

Authors:  Cristina Cristofoletti; Antonella Bresin; Martina Fioretti; Giandomenico Russo; Maria Grazia Narducci
Journal:  Cancers (Basel)       Date:  2022-06-09       Impact factor: 6.575

Review 2.  Emerging Role of T-cell Receptor Constant β Chain-1 (TRBC1) Expression in the Flow Cytometric Diagnosis of T-cell Malignancies.

Authors:  Pedro Horna; Min Shi; Horatiu Olteanu; Ulrika Johansson
Journal:  Int J Mol Sci       Date:  2021-02-12       Impact factor: 5.923

Review 3.  CD26/DPP-4 in Chronic Myeloid Leukemia.

Authors:  Anna Sicuranza; Donatella Raspadori; Monica Bocchia
Journal:  Cancers (Basel)       Date:  2022-02-11       Impact factor: 6.639

4.  Sézary syndrome patient-derived models allow drug selection for personalized therapy.

Authors:  Fernando Gallardo; Evelyn Andrades; Arnau Iglesias; Jessica González; Laura Solé; Yolanda Guillén; Gonzalo Blanco; Luis Colomo; Eva Gimeno; David Conde; Eva Rodriguez; Isabel Bielsa-Marso; Mar Iglesias; Beatriz Bellosillo; Ramon M Pujol; José R Regueiro; Anna Bigas; Lluís Espinosa
Journal:  Blood Adv       Date:  2022-06-14

5.  PD-1 combined with TRBC1 and pan-T cell antibodies for robustly monitoring angioimmunoblastic T-cell lymphoma.

Authors:  Chunyan Wang; Li Zhu; Songya Liu; Shujuan Yi; Min Xiao; Yicheng Zhang; Xia Mao
Journal:  Front Med (Lausanne)       Date:  2022-09-08

Review 6.  Flow cytometry for the assessment of blood tumour burden in cutaneous T-cell lymphoma: towards a standardized approach.

Authors:  Maarten H Vermeer; Helene Moins-Teisserenc; Martine Bagot; Pietro Quaglino; Sean Whittaker
Journal:  Br J Dermatol       Date:  2022-05-03       Impact factor: 11.113

7.  CD158k and PD-1 expressions define heterogeneous subtypes of Sezary syndrome.

Authors:  Inès Vergnolle; Claudia Douat-Beyries; Serge Boulinguez; Jean-Baptiste Rieu; Jean-Philippe Vial; Rolande Baracou; Sylvie Boudot; Aurore Cazeneuve; Sophie Chaugne; Martine Durand; Sylvie Estival; Nicolas Lablanche; Marie-Laure Nicolau-Travers; Emilie Tournier; Laurence Lamant; François Vergez
Journal:  Blood Adv       Date:  2022-03-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.